bibliographicCitation |
Kamei J, Yokoyama H, Niki T, Suda R, Sugihara T, Fujisaki A, Ando S, Iwami D, Fujimura T. Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney. IJU Case Rep. 2022 May;5(3):199–202. PMID: 35509786; PMCID: PMC9057750. |